Healthcare sector company Elevance Health posted a -2.0% performance today, while the S&P 500 returned 0.76%.
21 analysts are following Elevance Health and have set target prices ranging from $500 to $620 per share. On average, they have given the company a rating of buy. At today's prices, ELV is trading -15.12% away from its average analyst target price of $579.95 per share.
Over the last year, ELV's share price has increased by 13.6%, which represents a difference of 22.0% when compared to the S&P 500. The stock's 52 week high is $549.52 per share whereas its 52 week low is $431.5. With an average free cash flow of $7,309,333,333.3 that have been growing at an average rate of 34.6% over the last four years, Elevance Health is in a position to continue its strong stock performance trend.
|Date Reported||Cash Flow from Operations ($ MM)||Capital expenditures ($ MM)||Free Cash Flow ($ MM)||YoY Growth (%)|